Wall Street Zen Downgrades JBS (NYSE:JBS) to Sell

JBS (NYSE:JBSGet Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

Several other brokerages also recently weighed in on JBS. JPMorgan Chase & Co. lowered their price objective on JBS from $18.50 to $18.00 and set an “overweight” rating for the company in a research report on Monday, June 29th. UBS Group set a $17.00 target price on shares of JBS in a research note on Tuesday, May 19th. Zacks Research upgraded shares of JBS from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. Barclays dropped their price target on shares of JBS from $21.00 to $20.00 and set an “overweight” rating for the company in a research report on Thursday, July 16th. Finally, Weiss Ratings lowered shares of JBS from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, June 29th. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, JBS currently has an average rating of “Buy” and an average price target of $18.75.

View Our Latest Analysis on JBS

JBS Stock Performance

JBS stock opened at $12.30 on Friday. The firm has a fifty day simple moving average of $12.25 and a two-hundred day simple moving average of $14.69. The company has a quick ratio of 0.77, a current ratio of 1.50 and a debt-to-equity ratio of 2.42. JBS has a twelve month low of $11.49 and a twelve month high of $18.65. The company has a market capitalization of $9.54 billion and a PE ratio of 7.73.

JBS (NYSE:JBSGet Free Report) last issued its earnings results on Tuesday, May 12th. The company reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.08). JBS had a net margin of 1.98% and a return on equity of 19.28%. The company had revenue of $21.61 billion for the quarter. JBS’s revenue was up 10.7% compared to the same quarter last year. Research analysts expect that JBS will post 1.45 EPS for the current year.

Institutional Trading of JBS

Institutional investors and hedge funds have recently bought and sold shares of the stock. BNDES Participacoes S.A. bought a new stake in JBS during the 4th quarter valued at approximately $2,874,074,000. Davis Selected Advisers bought a new position in shares of JBS in the 4th quarter worth approximately $170,945,000. Banco BTG Pactual S.A. bought a new position in shares of JBS in the 3rd quarter worth approximately $143,175,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of JBS by 117.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 7,687,775 shares of the company’s stock valued at $138,072,000 after purchasing an additional 4,147,304 shares during the period. Finally, Ameriprise Financial Inc. boosted its position in shares of JBS by 23,891.7% during the third quarter. Ameriprise Financial Inc. now owns 6,583,073 shares of the company’s stock valued at $98,285,000 after purchasing an additional 6,555,634 shares in the last quarter.

JBS Company Profile

(Get Free Report)

JBS SA is a global leader in the production and processing of meat products, with a focus on beef, pork and poultry. Headquartered in São Paulo, Brazil, the company operates through an extensive network of owned facilities and partnerships that span the Americas, Europe and the Asia-Pacific region. JBS supplies fresh, frozen and value-added protein solutions for retail, foodservice and industrial customers, and is active across the entire supply chain—from livestock procurement and feed production to slaughtering, processing, packaging and distribution.

Founded in 1953 by José Batista Sobrinho in Anápolis, Goiás, JBS began as a small slaughterhouse and expanded rapidly through strategic acquisitions and organic growth.

Read More

Analyst Recommendations for JBS (NYSE:JBS)

Receive News & Ratings for JBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JBS and related companies with MarketBeat.com's FREE daily email newsletter.